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The counterfeit medicinal products are not clearly defined in current legislation, namely 
Poison Act 1952 and Regulations, the Sale of Drugs Act (SODA) 1952 and Control of 
Drugs and Cosmetic Regulation (CDCR) 1984. All cases pertaining to counterfeit 
medicinal products will be deal under provision of one of the acts or regulation stated. The 
main issues that contributes to this problem are the counterfeit medicines were not define 
and no specific provision for the offence regarding counterfeit medicine in the legislations, 
making difficulties for the drug enforcement officers in performing their duties. Absence 
or certain drug enforcement powers and low penalty imposed to the offence that related to 
the counterfeit offence does not reflect the seriousness of the offence towards society. 
Several flaws in the provision and low penalties imposed will lead to repeated offences 
related to counterfeit medicines. Current legislation seems to be inadequate in controlling 
the issue of counterfeit medicines in Malaysia. The United States’   legislation   is   chosen   
as   comparison   since   this   country   has   an established legal framework in controlling 
the counterfeit medicines in their country.  The aim of this study are to examine the 
adequacy of current legal framework in controlling counterfeit medicines in Malaysia, to 
investigate the laws in the United States and the established mechanism that prevents the 
counterfeit medicines from reaching their citizens and lastly, to propose suitable methods 
of improvement in preventing the counterfeits medicines in Malaysia. This research are 
carried out using a qualitative method, with combination of doctrinal research and semi-
structured interview. This study may contribute towards more effective control of 
counterfeit medicines in Malaysia and helps to assist policy makers in implementing and 
improving current laws and regulations pertaining this issue and fill up the lacuna in the 
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